Berman Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $100K | Buy |
243
+44
| +22% | +$18.1K | 0.02% | 440 |
|
|
2021
Q2 | $73K | Buy |
199
+14
| +8% | +$5.14K | 0.01% | 453 |
|
|
2021
Q1 | $53K | Buy |
185
+41
| +28% | +$11.7K | 0.01% | 458 |
|
|
2020
Q4 | $34K | Buy |
144
+43
| +43% | +$10.2K | 0.01% | 506 |
|
|
2020
Q3 | $22K | Sell |
101
-8
| -7% | -$1.74K | 0.01% | 546 |
|
|
2020
Q2 | $19K | Buy |
109
+14
| +15% | +$2.44K | 0.01% | 553 |
|
|
2020
Q1 | $11K | Hold |
95
| – | – | ﹤0.01% | 638 |
|
|
2019
Q4 | $14K | Hold |
95
| – | – | ﹤0.01% | 631 |
|
|
2019
Q3 | $12K | Buy |
95
+20
| +27% | +$2.53K | ﹤0.01% | 655 |
|
|
2019
Q2 | $10K | Buy |
75
+40
| +114% | +$5.33K | ﹤0.01% | 715 |
|
|
2019
Q1 | $5K | Buy |
35
+9
| +35% | +$1.29K | ﹤0.01% | 855 |
|
|
2018
Q4 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 854 |
|